These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276 [TBL] [Abstract][Full Text] [Related]
9. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
10. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704 [TBL] [Abstract][Full Text] [Related]
11. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320 [TBL] [Abstract][Full Text] [Related]
12. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Ishimura T; Sakai I; Hara I; Eto H; Miyake H Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540 [TBL] [Abstract][Full Text] [Related]
14. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070 [TBL] [Abstract][Full Text] [Related]
15. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Katz MD; Serrano MF; Humphrey PA; Grubb RL; Skolarus TA; Gao F; Kibel AS Urol Oncol; 2011; 29(6):738-44. PubMed ID: 19914106 [TBL] [Abstract][Full Text] [Related]
16. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666 [TBL] [Abstract][Full Text] [Related]
19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases. Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201 [TBL] [Abstract][Full Text] [Related]